![Kate Priestman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kate Priestman
Director/Board Member at
OXFORD NANOPORE TECHNOLOGIES PLC
Net worth: 63 064 $ as of 29/04/2026
Profile
Kate Sophie Priestman currently works at Oxford Nanopore Technologies Plc, as Senior Independent Non-Executive Director from 2024, GlaxoSmithKline Intellectual Property (No.2) Ltd., as Director from 2016, GlaxoSmithKline Intellectual Property Management Ltd., as Director, GlaxoSmithKline Intellectual Property Development Ltd., as Director, GlaxoSmithKline Intellectual Property (No.
3) Ltd., as Director from 2018, GlaxoSmithKline Intellectual Property (No.
4) Ltd., as Director from 2018, Royal Botanical Gardens, as Trustee, and CSL Ltd., as Chief Corporate & External Affairs Officer from 2023.
Ms. Priestman also formerly worked at GlaxoSmithKline Intellectual Property Ltd., as Director and GSK Plc, as SVP-Portfolio, Research & Development Strategy.
Ms. Priestman received her undergraduate degree from The University of Nottingham.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2025 | 41,290 ( 0% ) | 63 064 $ | 29/04/2026 |
Kate Priestman active positions
| Companies | Position | Start |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Director/Board Member | 12/07/2023 |
| CSL LIMITED | Corporate Officer/Principal | 31/08/2023 |
GlaxoSmithKline Intellectual Property Management Ltd.
 GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Director/Board Member | - |
GlaxoSmithKline Intellectual Property (No.2) Ltd.
 GlaxoSmithKline Intellectual Property (No.2) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Director/Board Member | 08/12/2016 |
Glaxosmithkline Intellectual Property Development Ltd.
 Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 08/12/2016 |
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
 GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development, enhancement, maintenance, protection and exploitation of intellectual properties | Director/Board Member | 23/07/2018 |
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
 GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines, vaccines and consumer healthcare products | Director/Board Member | 10/12/2018 |
Royal Botanical Gardens | Director/Board Member | - |
Former positions of Kate Priestman
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline Intellectual Property Ltd.
 GlaxoSmithKline Intellectual Property Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Director/Board Member | 27/10/2022 |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Kate Priestman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Oxford Nanopore Technologies Plc
 Oxford Nanopore Technologies Plc Electronic Equipment/InstrumentsElectronic Technology Develops instruments for electronic detection and analysis of molecules | Electronic Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Botanical Gardens | |
GlaxoSmithKline Intellectual Property (No.2) Ltd.
GlaxoSmithKline Intellectual Property (No.2) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
GlaxoSmithKline Intellectual Property Management Ltd.
GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Glaxosmithkline Intellectual Property Development Ltd.
Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
GlaxoSmithKline Intellectual Property Ltd.
GlaxoSmithKline Intellectual Property Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development, enhancement, maintenance, protection and exploitation of intellectual properties | Commercial Services |
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines, vaccines and consumer healthcare products | Health Technology |
- Stock Market
- Insiders
- Kate Priestman
